Prescribing is a complex task and a high-risk area of clinical practice. Poor prescribing occurs across staff grades and settings but new prescribers are attributed much of the blame. New prescribers are frequently neither confident nor competent to prescribe and they are likely to have different support and development needs than their more experienced colleagues.
Introduction
Prescribing is a complex, challenging task and a high-risk area of clinical practice (1).
Prescribing errors are common, affecting 7% medication orders, 2% patient days and 50% hospital admissions (2) . Studies have identified a range of factors underpinning poor prescribing at individual, environmental and organisational levels (3) . These include lack of training, low perceived task importance and lack of awareness of errors, as well as increasingly complex polypharmacy and patient factors, lack of standardization, and particular care environments (4-6).
There is evidence of poor prescribing across different grades of staff and in different settings (5) with new prescribers in particular being attributed a lot of the blame (5, 7) . Studies have found that new prescribers are neither confident nor competent when prescribing, both by their own assessment and that of their supervisors (8) (9) (10) . Many excellent initiatives have focussed on improving prescribing knowledge and technical skills (e.g. Hospital Pharmacy
Initiative (11) ; Medical Schools Councils Safe Prescribing Working Group (12) ). However improving prescribing knowledge and technical skills is not enough. Prescribing is a complex mix of knowledge, skills and behaviours and there is no simple relationship between them (13, 14) . The skills and experience of new prescribers must develop as they work within an environment where any positive gains may be negated by the numerous complex and overwhelming pressures that may influence prescribing behaviour.
The behaviour change literature is large and growing, supported by research funding to explore the theory and practice of behaviour change, and the development and evaluation This is a post-print author's draft of an article accepted for publication in the journal British Journal of Clinical Pharmacology 2013. DOI:10.1111/j. 1365-2125.2012 .04397.x 6 of behaviour change interventions. The challenges inherent in studying behaviour change are widely recognised. Behaviour change not only involves individual capability, opportunity and motivation but the fact that it takes place in a complex healthcare system adds another layer of complexity to the equation (15) . There is a plethora of behaviour change theories and frameworks, and behaviour change interventions are equally diverse, leading to challenges of nomenclature (16) . A useful way of categorising types of intervention is offered by Bero et al. (17) and this has been adopted in systematic reviews that aimed to determine educational strategies that were effective in changing physician performance and healthcare outcomes (but not necessarily prescribing behaviours) (18, 19). Davis et al. (19) included only randomised controlled trials and found that commonly used educational approaches like didactic presentations had little impact, whereas reminders, patientmediated interventions, outreach visits, opinion leaders and multifaceted activities were more effective. Bloom (18) reviewed systematic reviews to examine effectiveness of current CME tools and techniques in changing physician clinical practices and improving patient health outcomes and found that interactive techniques such as audit/feedback, academic detailing/outreach and reminders were more effective at changing physician care and patient outcomes than guidelines, opinion leaders, didactic presentations and printed information. Unfortunately, Bloom concluded that "Even though the cost-effective CME techniques have been proven, use of least-effective ones predominates".
In order to inform the design of educational interventions that can change the behaviours of new prescribers, we conducted a systematic review of existing interventions. There is no similar study to our knowledge. The most similar review was conducted by Gill et al (20) but it had a narrow methodological scope (only randomised controlled trials and non-equivalent This is a post-print author's draft of an article accepted for publication in the journal British Journal of Clinical Pharmacology 2013. DOI:10.1111/j.1365-2125.2012.04397.x 7 group designs), did not distinguish between grades of prescriber and is now out of date (only including studies up until 1994). Our study will update this review by identifying educational interventions that aimed to change the behaviour of new prescribers in hospital settings using a deliberately inclusive approach to definitions of educational interventions and study design.
Methods

Search Strategy
The databases used in the systematic review by Gill et al. (20) that are still in use were searched (Embase; Medline; SIGLE), in addition to Cinahl and PsychINFO. The searches were carried out on the 8 th and 9 th of November 2010 and searched for relevant items published between 1994 and November 2010.
The databases were searched for the following free text keywords in a variety of combinations "prescribing or drug administration or drug prescription or drug utilisation or drug utilization or drug prescription" and "medical education or continuing medical education or nursing education or dental education or clinical education" depending on the database. Subject headings relevant to each database were also used for example MeSH and Emtree. See Table 1 for details of the search used in Medline.
The bibliographies of included papers identified by our search of electronic databases were searched for relevant items by NB & KM. Abstracts were sought for the papers that were considered to be potentially relevant. The inclusion criteria were then applied to these This is a post-print author's draft of an article accepted for publication in the journal British Journal of Clinical Pharmacology 2013. DOI:10.1111/j.1365-2125.2012.04397.x 8 papers. In addition, the title, abstract or keywords needed to contain the words education to keep in line with our search strategy.
Inclusion Criteria
For the purposes of this review, prescribing was defined as the act of determining what medication a patient should have and the correct dosage and duration of treatment (21) .
The following inclusion criteria were adopted:
 Aspect of prescribing -all studies that focused on developing one or more aspect of prescribing as defined above. Studies focusing only on drug administration were not included.
 Study design -all study designs were included.
 Types of settings -all studies that were conducted in hospital settings. This was the setting we were most interested in as the purpose of the review was to inform the design of an educational intervention that develops the behavioural aspects of prescribing in new prescribers, and the vast majority of new prescribers are based in hospital settings. Furthermore we felt that the interventions and reasons underpinning why they might work may be different between hospital and primary care.
 Types of participants -all studies that included doctors, nurses, dentists or other healthcare professionals that prescribe and are in the early stages of their careers i.e. qualified but <2 years post graduation. If the study participants involved all This is a post-print author's draft of an article accepted for publication in the journal British Journal of Clinical Pharmacology 2013. DOI:10.1111/j.1365-2125.2012.04397.x 9 prescribers in a hospital setting (which would include new prescribers) then it was included.
 Types of intervention -interventions or resources that focus on changing or developing the behavioural aspects of prescribing.
 Outcome measures -all prescribing related outcome measures were accepted.
 Language -studies published in English language.
Data Collection and Analysis
One review author (NB) assessed the potential relevance of all titles and abstracts identified from the electronic searches. As a reliability measure, the first 10% of the titles and abstracts were assessed independently and then compared by the two review authors (NB & KM). If a difference was found the issue was discussed. The remaining title and abstracts (90%) were assessed independently by NB. If NB had any doubts about particular studies while assessing them they were resolved by discussion with KM. A categorisation system was developed to categorise excluded papers (Figure 1 ).
Data Extraction and Quality Appraisal
The papers of all eligible studies were obtained and read in full and data were extracted by each review author. Data were extracted independently using a standardised review form.
Interventions were categorised using the same classification as the Gill(20) study which was based on Bero et al (see Table 2 ). Where possible the pre and post test scores were extracted but some studies failed to report these and in these cases the numerical or percentage change were reported instead. The effectiveness of interventions were This is a post-print author's draft of an article accepted for publication in the journal British Journal of Clinical Pharmacology 2013. DOI:10.1111/j.1365-2125.2012.04397.x 10 categorised using a modified version of the classification system used in the Gill (20) study (see Table 3 ). It was not possible to use an identical framework to Gill et al. because this relied on the statistical significance of change in the outcomes measured and very few of our included studies conducted this type of analysis. Our modified approach is described in Table 3 and the categorisation was applied independently by both NB and KM. >95% agreement was reached between KM and NB using this method. The few differences that were found were discussed and agreement was reached.
The quality of studies were appraised using the medical education research study quality instrument (MERSQI) (Table 4) (22) . This tool was the most appropriate for this review because the majority of interventions included in the study had an educational, conference or training element to the intervention. Furthermore the majority of studies were observational or experimental and the MERSQI was designed for these study designs. The six items on the MERSQI scale (study design, sampling, type of data, validity of evaluation instrument, data analysis, and outcomes) were scored on a scale of 1 to 3 and summed to determine a total MERSQI score. The maximum score for each domain was 3, producing a maximum possible MERSQI score of 18 and potential range of 5 to 18. The total MERSQI score was calculated as the percentage of total achievable points (accounting for "non applicable" responses) and then adjusted to a standard denominator of 18 to allow for comparison of scores across studies (22) . Both reviewers independently scored the papers using the MERSQI tool and consistent scores were found. 
Results
Literature Identified
The search identified 5,966 potentially relevant articles and after the exclusions were applied 53 articles satisfied the inclusion criteria (Figure 1 ). Checking the references of the 53 included items identified 11 more relevant studies. The 64 studies included in the analysis are listed in Table 5 .
Description of Studies
Only 13% of interventions specifically focussed on new prescribers. The majority of studies were conducted in the USA and Canada (39%) and Europe (33%) ( Table 5 ). In terms of clinical area, 38% were conducted in internal medicine, 27% were carried out in all clinical areas and 13% were carried out in paediatrics. A variety of drug types were involved, with the largest group being antibiotics (32%).
The majority of studies were single group pre test and post test (72% n=46), with the remainder being either non-randomized 2 group (11%, n=7), randomised control trials (9%, n=6) and single group cross-sectional or single group post test only (8%, n=5). Nearly all of the interventions were multifaceted (89%) using a variety of combinations of interventions.
Within the 64 eligible studies there were 157 separate interventions (Table 2) ++. Of the 17 (27%) most successful strategies (classified as ++) 6 provided specific feedback to prescribers (e.g. audit and feedback (23-28) and 7 required active engagement with the process (e.g. reminders (26, (29) (30) (31) (32) (33) (34) . However, 7 of the 8 studies classified as ineffective also contained these intervention types (35) (36) (37) (38) (39) (40) (41) .
Quality of Studies
Total MERSQI scores among the 64 studies ranged from 6 to 18 with a mean (SD) of 13.3 (1.7) ( Table 6 ). Mean domain scores were highest for type of data (3.0), data analysis (2.8) and outcomes (2.0). Only 19.4% of studies were multi-institutional. All of the studies measured a behavioural outcome, two of which included patient outcomes.
Discussion
The aim of this systematic review was to identify educational interventions that aimed to change behaviour of new prescribers. A previous systematic review explored this topic but had a narrow methodological scope, did not focus on new prescribers and is now out of date. We focussed on the hospital setting since this is where the majority of new prescribers are based and since we felt the issues facing prescribers in primary and secondary care were probably different, and might require different strategies for behaviour change.
We identified a reasonable size literature relevant to our aim. However, only 19% of studies distinguished between different grades of prescriber and even fewer (13%) focussed on new prescribers. A systematic review investigating the effectiveness of education interventions This is a post-print author's draft of an article accepted for publication in the journal British Journal of Clinical Pharmacology 2013. DOI:10.1111/j.1365-2125.2012.04397.x 13 whose target population was medical students and junior doctors similarly found a very small number of studies on junior doctors (3). The limited focus on new prescribers probably reflects the predominant use of before and after studies where the outcome measure was hospital pharmacy data or patient notes. It is not possible and / or labour intensive to differentiate between grades of staff in these data sources. New prescribers are a very distinct group with different educational needs than more experienced prescribers and we think that different behaviour change strategies will be effective thus it is important that educational interventions are designed specifically to target this group.
The educational interventions reported in the included studies were varied and were mainly used in various combinations. The findings show that 72% of interventions were deemed effective in changing prescribing behaviour in the intended direction. However, similar to the Gill et al. study (20) , no clear differences in the effectiveness of particular types or combinations of interventions could be deciphered. This contrasts with the Davis (19), Bloom (18) and Grindod (42) studies which found particular types of interventions like audit and feedback, reminders, outreach were consistently effective (although none of these studies contained information on the sustainability of effect of these interventions). The inconsistencies in findings is probably related to the fact that prescribing behaviour is The strengths of the research approach were the considerable efforts that went into locating relevant studies. Publication bias is the most important source of bias in systematic reviews (46) . This is likely the case in this study, given that the majority of the interventions were effective. One wonders whether the authors would have sought to publish them if they had not had the desired effect.
A limitation of this review is the subjective nature of the direction and magnitude of the effect scores. While the MERSQI scale was helpful for assessing the quality of studies, like most quality assessment tools it did have some limitations. The perfect score of 3.0 for type of data was because the quality scale is not applicable to prescribing interventions included in this review, so by nature of the inclusion criteria, all the studies got a perfect score on this component. Other limitations were the reliance on pre-post test designs which can be confounded by improvement of prescriber with time and clinical experience, another is the possible absence of blinding in studies with risk of observer bias, and finally selective outcome reporting with a tendency to report favourable outcome measures in the manuscript.
In terms of future research, behaviour change strategies targeting specific grades of prescriber are urgently needed if we are to reduce the morbidity and mortality resulting from prescribing errors. Quantitative studies (such as a before and after study with a control hospital, or an RCT) could be enhanced by the inclusion of a process evaluation to unpick the possible reasons underpinning prescribing behaviours (47) as none of the studies in this review included this element. 
Marketing:
Use of personal interviewing, group discussion (focus groups) or a survey of targeted providers to identify barriers to change and the subsequent design of an intervention and refinement. 9 6
Patient-mediated interventions:
Any intervention aimed at changing the performance of health care providers for which information was sought from or given directly to patients by others (e.g. direct mailings to patients, patient counselling delivered by others, or clinical information collected directly from patients and given to the provider) 1 1
Local opinion leader:
Use of providers explicitly nominated by their colleagues to be educationally influential 1 1
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